Abstract:Background Evidence-based medicine has come into its second decade. How prepared clinicians are in practicing it in particular in developing countries remains unclear. Thus we conducted this survey of physicians in urban hospitals in China to determine the size of the gap between research evidence and physicians' knowledge and practice regarding antihypertensive drugs for primary prevention of cardiovascular diseases in China.Methods A cross sectional survey by a face-to-face interview was conducted in 20 tertiary general hospitals in China in 2005. A total of 444 physicians (mostly cardiologists) in internal medicine who had treated at least one hypertensive patient in the past 12 months were invited for the interview on their perception of the cardiovascular risk of hypertension, the magnitude of the benefit of antihypertensive drugs, knowledge on the overall risk approach, first-line drugs used, the risk above which drug treatment is recommended, and knowledge on evidence-based medicine.Results A total of 444 of the 468 eligible physicians were successfully interviewed with a response rate of 94.9%. They estimated that a hypertensive man with an actual 5-year cardiovascular risk of 8.4% would have a 5-year cardiovascular risk of 40% (95% Cl: 38% to 42%) if not treated, and have an absolute risk reduction and relative risk reduction from drug treatment by 20% (95% Cl: 18% to 22%) and 39% (95% Cl: 37% to 42%) respectively, as compared to 3.3% and 33% respectively shown in research evidence. On average, the physicians would recommend drug treatment at a number needed to treat (NNT) of 368 or smaller, as compared to the actual NNT of 50 for drug treatment in an average hypertensive Chinese. Fifty-five percent (95% Cl: 50% to 59%) of them had never intently used the national hypertension guidelines. The majority still prescribed drugs primarily based on blood pressure alone by ignoring other risk factors or the overall risk and 78% (95 % Cl: 76% to 83%) used new expensive drugs such as calcium channel blockers and angiotensin converting enzyme (ACE) inhibitors as first-line treatment. Only 13% (95% Cl: 9% to 18%) could correctly interpret the NNT. Forty-three percent (95% Cl: 39% to 48%) did not know the randomized controlled trial was scientifically the most rigorous among other study designs for evaluating the effectiveness of anti-hypertensive drugs. Ninety-two percent (95% Cl: 90% to 94%) did not know they could start by searching systematic reviews when looking for evidence on the effectiveness of anti-hypertensive drugs as opposed to trials. Ninety-six percent (95% Cl: 94% to 98%) did not know the Cochrane Library was an important source of systematic reviews.Conclusions The surveyed physicians significantly over-estimated the cardiovascular risk of hypertension and the benefit of drug treatment, and had insufficient knowledge on the overall risk approach. They recommended drug treatment at a cardiovascular risk which was even much lower than the cutoff suggested for western populations, which would make many more people eligible for drug treatment. They also tended to prescribe new expensive drugs although the older cheaper ones may be more appropriate in many patients. They showed inappropriate knowledge on the basics of evidence-based medicine. Chin Med J 2011;124(8):1235-1241

Current Status of Glucose Test Prescription for Hypertensive Outpatients

P243Glucose Metabolism and Blood Pressure Control Status in Professional Hypertension Clinics in China

[Blood Pressure Control and Glucose Metabolism Status in Hypertension Specialty Clinics in China].

[Status of Glucose Metabolism in Chinese Essential Hypertensive Patients].

Blood Glucose Profile of Patients with Essential Hypertension in China

Utilization Pattern of Antihypertensive Drugs in Chinese Diabetics

Glucose Metabolism in Outpatients with New-Onset Hypertension in Chinese Han Population

Hypertension in China: the Gap Between Policy and Practice

Detecting diabetic risk using the oral glucose tolerance test in Chinese patients with hypertension: a cross-sectional study

Gap Between Evidence and Physicians' Knowledge and Practice Regarding Hypertension and Its Drug Treatment: A Survey in A Chinese City

Glycemic Control Rate of T2DM Outpatients in China: A Multi-Center Survey

PS 06-21 THE INCIDENCE OF CARDIOVASCULAR RISK FACTORS/CLINICAL CONDITIONS AMONG CHINESE HYPERTENSIVE OUTPATIENTS

Prevalence of Diabetes and Impaired Fasting Glucose in Hypertensive Adults in Rural China.

Investigation of Daily Glucose Profile of Inpatients in Non-endocrinology Departments in Chinese Population.

Hyperglycemia and Blood Pressure Treatment Goal: A Cross Sectional Survey of 18350 Patients with Type 2 Diabetes in 77 Tertiary Hospitals in China

Knowledge gap and prescribing patterns of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors among Chinese doctors

Prevalence and Associated Factors of Diabetes and Impaired Fasting Glucose in Chinese Hypertensive Adults Aged 45 to 75 Years

[The 10-Year Stroke Risk in Hypertensive Outpatients Combined with Diabetes in Cardiovascular Clinics of 36 Tertiary Hospitals in China].

Cross-sectional study on the prevalence of abnormal glucose metabolism in patients with coronary artery disease in China——China Heart Survery

Prevalence, Awareness, Treatment, and Control of Hypertension in the Non-Dialysis Chronic Kidney Disease Patients

Improved but Still Poor Status of Hypertension Control in China: a Cross-Sectional Analysis of Screening Data from 183 478 Patients in Tertiary Hospitals